Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Safety and Effectiveness of the HIT Reverse HRS
NCT05357378 · View on ClinicalTrials.gov ↗
Study Summary
The purpose of this study is to determine if the use of the HIT Reverse Hip Replacement System is safe and effective in patients undergoing total hip replacement. We will determine whether it is safe and effective by comparing it to the control devices.
Conditions Studied
Interventions
- DEVICE Hip Innovation Technology Reverse Hip Replacement System
- DEVICE Already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination.
Study Locations (6)
Florida
- Miami Institute for Joint Reconstruction — Miami
- Advent Health Hospital, Carrollwood — Tampa
- Tampa General Health / Florida Orthopedic Institute — Tampa
Maryland
- LifeBridge Health Rubin Institute for Advanced Orthopedics — Baltimore
New Jersey
- Division of Orthopaedic Surgery — Somers Point
Ohio
- JIS Orthopedics — New Albany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2035-07-15 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05357378
The ClinicalTrials.gov registry entry for NCT05357378 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hip Innovation Technology, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 4 conditions, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 2 interventions — of which Hip Innovation Technology Reverse Hip Replacement System is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05357378 reports 6 study locations spanning 4 distinct geographic areas — top geographies include Florida, Maryland, New Jersey. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05357378 about?
NCT05357378 is a clinical study titled "Safety and Effectiveness of the HIT Reverse HRS". The purpose of this study is to determine if the use of the HIT Reverse Hip Replacement System is safe and effective in patients undergoing total hip replacement. We will determine whether it is safe and effective by comparing it to the control devices.
What is the current status of trial NCT05357378?
This trial is currently recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2022-07-15. Estimated completion is 2035-07-15.
What conditions does trial NCT05357378 study?
This clinical trial studies the following conditions: Osteoarthritis, Hip, Degenerative Joint Disease, Avascular Necrosis of Hip, Traumatic Arthropathy-Hip. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05357378?
The interventions under investigation include: Hip Innovation Technology Reverse Hip Replacement System (DEVICE), Already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination. (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05357378?
This trial is sponsored by Hip Innovation Technology, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05357378 being conducted?
This trial has 6 study locations across Florida, Maryland, New Jersey, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.